Login to your account
Don’t have an account?
Create a Free Account
Multimedia Library
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
Subthalamic nucleus (STN) deep brain stimulation (DBS) improves quality of life (QoL), motor, and non-motor symptoms (NMS) in Parkinson's disease (PD). Few studies have investigated the influence of the location of neurostimulation on NMS.Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease
Subthalamic nucleus (STN) deep brain stimulation (DBS) improves quality of life (QoL), motor, and non-motor symptoms (NMS) in advanced Parkinson's disease (PD). However, considerable inter-individual variability has been observed for QoL outcome.Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease
Subthalamic nucleus (STN) deep brain stimulation (DBS) is well established for the symptomatic treatment of Parkinson's disease (PD) improving motor symptoms, activities of daily living (ADL), and quality of life (QoL) [1–3]. Non-motor symptoms (NMS) play a crucial role for QoL in patients with PD [4,5]. Long-term effects of DBS on neuropsychological [6,7] and neuropsychiatric symptoms [8,9] have been studied. However, these symptoms contribute only to a part of NMS in patients with PD. Previously published studies on a wider range of NMS have methodological limitations due to a lack of objective clinician-based [10], patient-based [11,12] or any validated assessment at all [12], and small cohort sizes of only 10 [13,14] or 11 subjects followed up on 6 month [12].
